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Two poliovirus mutants were isolated that contain an oligonucleotide linker insertion in the 2C-coding region
of the viral genome. One, 2C-31, has a strongly temperature-sensitive phenotype and the other, 2C-32, forms
small plaques on HeLa cell monolayers at all temperatures. Both mutants have a severe temperature-sensitive
defect in viral RNA synthesis but little effect on the types of viral protein that are made. Temperature shift
experiments showed that the 2C function is continuously required for viral RNA synthesis to proceed. The 2C
mutants could be complemented in trans by mutants with mutations in other viral proteins. Protein 2C is also
the locus of the guanidine resistance and dependence mutants, a drug whose action also affects viral RNA
synthesis. Thus, protein 2C is one that is needed continually for viral RNA synthesis and, at least with these
temperature-sensitive alleles, can be provided in trans.
Poliovirus, a member of the picornavirus family, contains
a single plus-strand RNA genome of about 7.5 kilobases. The
viral genome encodes a single polyprotein that is proteoly-
tically cleaved to give rise to various viral proteins (13, 14,
22, 32). The structural proteins, which form the viral capsid,
are located at the amino-terminal P1 region, while the viral
polymerase (3D), a protease (3C), and the genome-linked
small peptide (VPg) are located at the carboxyl P3 region
(see map in Fig. 1). The central P2 region of the viral
polyprotein contains several polypeptides with poorly delin-
eated functions. Protein 2A appears to be involved in the
shutoff of host cell protein synthesis by infecting poliovirus
(3) and also contains a protease activity that is required for
the cleavage of the P1-P2 junction (35). Protein 2B is
involved in RNA synthesis (2). Mutations providing resis-
tance to and dependence on guanidine map to the 2C-coding
region of the viral genome (15, 23-25). Guanidine hydrochlo-
ride can completely inhibit poliovirus replication at millimo-
lar concentrations, and the major effect of guanidine appears
to be blockage of viral RNA synthesis (7, 8, 21), although the
mechanism of this effect remains obscure.
The genome of poliovirus type 1 (Mahoney) was the first
picornavirus genome to be cloned (26) and sequenced (16,
26). The finding that the cDNA clone was infectious when
transfected into mammalian cells (27) offered an opportunity
to study the biology of poliovirus through well-defined
mutants made by in vitro mutagenesis of the cDNA clone,
and several such mutants have been obtained (2, 3, 28, 30).
To study the function of polypeptide 2C, we made several
cDNA constructs that carried a linker insertion in the
2C-coding region. When transfected into HeLa cells, two
viable mutants were recovered, both of which were defec-
tive in viral RNA synthesis. Viral RNA synthesis at the
permissive temperature rapidly ceased when the tempera-
ture was shifted to the nonpermissive condition. The inabil-
ity of one of the mutants, 2C-31, to grow at the nonpermis-
sive temperature was reversed by coinfection with other




Cells and viruses. HeLa cells were maintained in suspen-
sion culture in the Joklik modification of minimal essential
medium supplemented with 7.5% horse serum (GIBCO
Laboratories, Grand Island, N.Y.). Wild-type poliovirus
was isolated from a single plaque derived from HeLa cells
transfected with a pSV2-polio plasmid as described previ-
ously (3, 27, 30).
Linker-insertion mutagenesis. All enzymes and linkers
were purchased from New England BioLabs, Inc. (Beverly,
Mass.) unless noted and used according to the protocols of
the manufacturer. The general method of linker-insertion
mutagenesis has been described previously (18, 30, 31).
Briefly, the plasmid pSV2-polio that contains the intact
infectious poliovirus type 1 (Mahoney) cDNA sequence was
digested partially with XbaI, BalI, BamHI, NsiI, SphI, or
XmnI. Alternatively, a plasmid containing only the poliovi-
rus cDNA sequence from nucleotide 3660 to nucleotide 6056
was used for NcoI or RsaI partial digestion. In both cases,
the full-length linearized plasmid fragments with a single cut
were then isolated from agarose gel for subsequent ligation
with a linker. The DNA fragments with 5' protruding ends
were first filled in with the Klenow fragment of DNA
polymerase I in the presence of all four deoxyribonucleo-
tides, and those with 3' protruding ends were treated with S1
nuclease (Sigma Chemical Co., St. Louis, Mo.). They were
then ligated with a DNA linker and T4 DNA ligase. The
DNA fragments with blunt ends were directly ligated with
the linker. After mapping with various restriction enzymes,
a BstEII (3925)-BglII (5601) fragment containing a linker
insertion in the 2C-coding sequence was cut from a plasmid
and ligated into the corresponding region of a second plas-
mid identical to pSV2-polio except that it does not contain
the EcoRI site present in pSV2-polio in the pBR-derived
sequence. All plasmids containing the inserted linker were
then selected on the basis of the newly introduced linker site
and recircularized through the unique linker sequence to
ensure a single-copy insertion. These plasmids were mapped
again with various restriction enzymes before they were
used to transfect HeLa cells. The sequences of the two
plasmids that gave mutant viruses 2C-31 and 2C-32 were
later verified by direct DNA sequencing through the region
that contains the inserted linker.
4016
POLIOVIRUS 2C MUTANTS 4017
5NC Pi *1' P2 - -1'- P3 *1I




t t " t t t tn
-TyrSer ThrSerArgSer ArgAsp- -MetAla Ar Ala MetAla-
2C-31 2C-32
FIG. 1. Locations of the inserted DNA linker in each of the 10 poliovirus cDNA constructs. Arrows indicate their relative positions in the
2C-coding region. The corresponding restriction sites in the cDNA sequence (23) are (from left to right): SphI (4154), RsaI (4502 and 4585),
BamHI (4600), XmnI (4684), NcoI (4728), NsiI (4830), Xbal (4886), BalI (4908), and NcoI (4911). An 8-bp EcoRl linker (5'-GGAATTCC-3')
was used for ligations with BamHI, NcoI, or XbaI fragments (pretreated with the Klenow fragment of DNA polymerase I), and a 10-bp EcoRI
linker (5'-CGGAATTCCG-3') was used for ligations with SphI or NsiI fragments (pretreated with S1 nuclease). For ligations with the
blunt-ended fragments created by RsaI, XmnI, or BalI digestion, a 6-bp SmaI linker (5'-CCCGGG-3') was used. The resultant insertions in
the amino acid sequence of 2C mutants are shown in boxes. gua R/D, Region in which guanidine-resistant and -dependent determinants were
mapped (15, 23, 24).
DNA transfection. At 24 h before transfection, HeLa cells
were harvested from suspension culture and plated onto
60-mm petri dishes at about 5 x 105 cells per dish. About 5
,ug of DNA from both the wild-type and linker-insertion-
mutagenized pSV2-polio plasmids was used in a single
transfection by the DEAE-dextran procedure (20). Immedi-
ately after transfection, HeLa cell dishes were overlaid with
1% agar in Dulbecco modified Eagle medium supplemented
with 5% fetal calf serum (GIBCO) and incubated at 32, 37, or
39.5°C for up to 7 days. Individual plaques were then
isolated from the agar overlayer and plaque purified again
before propagation of the virus in liquid culture.
Virus infections and metabolic labeling of infected cells. For
HeLa cell infections, about 0.5 x 106 to 1 x 106 cells growing
in suspension were collected by centrifugation and resus-
pended in 0.2 ml of minimal essential medium. Virus was
then added to the cell suspension and allowed to adsorb for
30 min at room temperature. After adsorption, the cells were
diluted in fresh medium and incubated at various tempera-
tures for periods of time specified for each experiment. For
protein labeling with [35S]methionine, medium was removed
by centrifugation several hours after infection and cell pel-
lets were resuspended in methionine-free minimal essential
medium. After a brief incubation, [35S]methionine (>800 Ci/
mmol; Dupont, NEN Research Products, Boston, Mass.)
was added to a final concentration of 50 xCi/ml. Incubation
of cells was continued for 30 min, and then incorporation
was stopped by placing the culture on ice. After being
washed three times with ice-cold phosphate-buffered saline,
the cell pellets were collected by centrifugation and lysed in
phospholysis buffer (1% Triton X-100, 0.5% sodium deoxy-
cholate, 0.1% sodium dodecyl sulfate [SDS] in phosphate-
buffered saline). Chromatin was removed by centrifugation,
and the supernatants were used for immunoprecipitation
with an anti-2C antiserum as described previously (3) or they
were used directly for SDS-polyacrylamide gel electropho-
resis essentially by the method of Laemmli (17).
For analysis of viral RNA synthesis, [3H]uridine (50 ,uCi/
ml; Dupont, NEN Research Products) was added several
hours after infection and the cells were then incubated in the
presence of 5 ,ug of actinomycin D per ml for various
periods. They were then lysed in phospholysis buffer, and
RNA was prepared from the cell lysates for analysis by
agarose gel electrophoresis (3).
Genetic complementation analysis. The methods for genetic
complementation among poliovirus mutants and the calcu-
lation of the complementation index have been described
previously (2).
RESULTS
Isolation and growth of poliovirus 2C mutants. Two small-
plaque mutants in protein 2C were created by site-directed
linker insertion: 2C-31 and 2C-32. Figure 1 shows the loca-
tions of linker insertions into the 2C region of poliovirus
cDNA constructs and the corresponding changes in amino
acid sequence in the two viable mutants. Eight other inser-
tions were apparently lethal to viral replication because no
virus was recovered when these constructs were used in the
transfection assay. The cDNA of 2C-31 contained a 12-base-
pair (bp) insertion (see legend to Fig. 1 for details) at position
4886 (according to reference 26) which resulted in a four-
amino-acid insertion in the 2C sequence. The construct of
2C-32 contained a 6-bp insertion at position 4908 resulting in
a two-amino-acid insertion. When the two cDNA constructs
were transfected into HeLa cells, they gave rise to viable
virus after 6 to 7 days of incubation at 32°C. At 39.5°C, no
virus was recovered from HeLa cells transfected with 2C-31
cDNA. The temperature-sensitive (ts) phenotype of 2C-31
was confirmed by single-cycle virus infection of HeLa cells.
At 39.5°C, the yield of 2C-31 in a single cycle of infection
was about 10-3 to 10-4 of the yield at 32°C (Fig. 2).
Furthermore, the relative titer of a viral stock at 39°C was
also about 1o-3 to 10-4 of the titer at 32°C (data not shown).
Even at the permissive temperature, the yield of 2C-31 was
about 100-fold lower than that of wild-type poliovirus (Fig.
2). A given stock of 2C-32 gave similar titers of small plaques
at all temperatures (data not shown); the yield at 39.5°C in a
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FIG. 2. Growth curves of mutant and wild-type (W.T.) poliovi-
ruses in a single cycle of infection. All infections were carried out in
a HeLa cell suspension (106 cells per ml) with a multiplicity of
infection of 10. At each time point, 1 ml of cell suspension was
taken, virus was released by three cycles of freeze-thawing, and
titers were determined by standard plaque assay on HeLa cells.
Infections done at 32°C; - - - - -, infections done at 39.5°C.
single-cycle infection was at least 10-fold less than that at
32°C, indicating a significant temperature sensitivity, al-
though not one sufficient to alter the efficiency of plaque
formation.
Protein synthesis in mutant-infected cells. The pattern of
viral protein synthesis and the concomitant shutoff of cellu-
lar protein synthesis by 2C mutants was examined by
labeling infected cells with [35S]methionine. At 39.5°C, a
temperature that significantly lowered the rate of growth of
2C-32 and completely restricted the growth of 2C-31, various
viral proteins including 2C were synthesized, albeit at a
lowered rate. Neither the cleavage of the various precursors
nor the mobility on SDS-polyacrylamide gels of the 2C
protein was affected by the mutations (Fig. 3). This was
further confirmed by SDS-polyacrylamide gel electropho-
retic analysis of mutant 2C proteins immunoprecipitated by
an anti-2C antiserum (Fig. 4). The low amount of viral
proteins being synthesized in the mutant-infected cells was
explained by the minimal amount of viral RNA made at
39.5°C (see below). The shutoff of cellular protein synthesis
by both mutants at 39.50C was somewhat delayed, but both
mutants were able to shut off host cell protein synthesis
completely by late during the infection cycle (Fig. 3; data not
shown). At 32°C, the overall pattern of viral protein synthe-
sis by both mutants was very similar to that of wild-type
virus (data not shown).
Viral RNA synthesis. To examine viral RNA synthesis by
the 2C mutants, HeLa cells were labeled with [3Hjuridine at
4.5 h (39.5°C) or 6 h (32°C) after infection and RNAs were
prepared from cell lysates 30 min later and analyzed by
agarose gel electrophoresis (Fig. 5). At 32°C, both 2C-31
(Fig. 5A, lane 2) and 2C-32 (Fig. 5A, lane 1) synthesized an
amount of viral RNA severalfold less than that of wild-type
virus (Fig. 5A, lane 3). Both single-stranded and double-
stranded viral RNAs were apparent. At 39.5°C, however,
there was very little if any viral RNA synthesis in 2C-31-













FIG. 3. Pattern of protein synthesis in virus-infected cells at
39.5°C. About 106 HeLa cells were used in a single infection with a
multiplicity of infection of 10, and 1/200th of the total cell lysates
prepared at 3 or 5 h after infection was loaded on each lane of an
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FIG. 4. Immunoprecipitation of viral protein from HeLa cells
infected for 5 h. Infection was at 39.5°C. An anti-2C antiserum
which also contains anti-P3 activity (3) was used. See the legend to
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FIG. 5. Viral RNA synthesized in infected HeLa cells analyzed
by electrophoresis through a native 1% agarose gel. Infections were
carried out at 32°C (A) or 39.5°C (B) for 6 or 4 h, respectively, with
a multiplicity of infection of 50. Samples analyzed were 1/10th of the
total RNA from 106 HeLa cells. Lanes 1, 2, and 3, RNA from
2C-32-, 2C-31-, and wild-type virus-infected HeLa cells, respec-
tively. ds vRNA, Double-stranded viral RNA; ss vRNA, single-
stranded viral RNA.
phenotype manifested by this mutant and suggested that
protein 2C is directly involved in the process of viral RNA
synthesis. This was supported by 2C-32-infected cells (Fig.
SB, lane 1) which showed a drastic reduction in viral RNA
synthesis correlating with temperature sensitivity of the
yield of 2C-32 in a single cycle of infection (Fig. 2).
When infections were done at the permissive temperature
for 6 h and then the temperature was shifted to the nonper-
missive condition, viral RNA synthesis in 2C-31-infected
cells rapidly ceased (Fig. 6B), while similar shifting had little
effect on RNA synthesis by wild-type virus (Fig. 6A). This
result indicates that the 2C protein accumulated during
infection at the permissive temperature in 2C-31-infected
cells could maintain viral RNA synthesis for only a short
period after the switch of temperature, suggesting that the
involvement of 2C in viral RNA synthesis is probably not
just an early event during poliovirus replication. Rather, the
continual presence and perhaps synthesis of this protein is
required to complete the replication cycle.
Genetic complementation analysis. To examine whether the
potential function of 2C could be provided in trans, we
coinfected HeLa cells with mutant 2C-31 and each of two
A B
1 2 3 4 1 2 3 4
ssvRNA-A
FIG. 6. Effect of a temperature upshift on viral RNA synthesis.
Infections were first carried out at 32°C for 6 h, and then the
temperature was shifted to 39.5°C for 15 min (lane 1), 30 min (lane
2), 45 min (lane 3), and 60 min (lane 4). [3H]uridine was added 15 min
before each sample was taken. (A) RNA samples from wild-type
virus-infected cells. (B) RNA samples from 2C-31-infected cells. ds
vRNA, Double-stranded viral RNA; ss vRNA, single-stranded viral
RNA.
small-plaque mutants with lesions elsewhere in the viral
genome. The first, 2B-11, contains a six-nucleotide insertion
at position 3933 in the 2B-coding region of the viral genome
(J.-P. Li and D. Baltimore, unpublished data). The second,
3D-3, contains a lesion in the sequence encoding the viral
polymerase, 3D (2). The growth of these two mutants is not
complementable by other mutants (2; unpublished observa-
tions). The virus yield for 2C-31 in a single cycle of infection
at 39.5°C could be increased several hundredfold by coin-
fection with one of the two small-plaque mutants (Table 1).
The increase in titer of 2C-31 in the mixed infection was
demonstrated by examining the phenotype of progeny virus
in individual plaques derived from the mixed infections:
more than 70 and 50% of the individual plaques derived from
2C-31 plus 2B-11 and 2C-31 plus 3D-3, respectively, con-
tained progeny virus with a ts phenotype. These results
clearly indicate that the function of 2C can be provided in
trans. With mutant 3D-3, the complementation was so
efficient that the yield of 2C-31 was only threefold less than
that of wild type.
DISCUSSION
By isolating mutants with a recognizable phenotype in
protein 2C, we partially characterized the function of the
protein. The protein is necessary for viral growth and
appears to be involved in viral RNA synthesis. Its function
must be performed continuously through the infection cycle,
and it can be provided in trans to the viral genome.
Previous data suggested that protein 2C is involved in
RNA synthesis. The high degree of amino acid sequence
conservation of protein 2C among picornaviruses (1, 10, 23)
argues for its importance, and the demonstration that 2C is
associated with the membrane-bound viral replication com-
plexes in poliovirus-infected cells (5, 6, 33) suggests that it is
inherent in the replication process. This perspective is
further supported by the observation that several guanidine-
resistant and guanidine-dependent poliovirus mutants map
to within the region that encodes protein 2C (15, 23-25).
Guanidine hydrochloride can block the growth of many
picornaviruses, including poliovirus, at millimolar concen-
trations (8, 9, 19, 29). The mechanism of guanidine action
has been a subject of debate, but one result of guanidine
action is a blockage of viral RNA synthesis, particularly that
of single-stranded RNA (7, 8, 21).
Our results also imply that protein 2C function is required
for effective viral RNA synthesis, but no studies prove that
it is directly involved in any particular step of viral RNA




Wild type 1.3 X 108 1.4 x 108
2C-31 5 x 104 5 x 102
2B-11 6.5 x 106 (ts, 0%) 9 x 106
3D-3 2 x 107 (ts, 0%) 1.5 X 107
2C-31 + 2B-11 3 x 107 (ts, .70%) 7 x 106 460
2C-31 + 3D-3 6 X 107 (ts, .50%) 2.2 x 107 760
" All single and mixed infections were carried out at 39.5°C for 4 h with a
multiplicity of infection of 5 for each virus.6 Titers of the viruses harvested from single or mixed infections containing
106 HeLa cells each in 2 ml of minimal essential medium. All titrations were
done on HeLa cell dishes at both 32 and 39.5°C.
' CI (complementation index) values for mutant 2C-31 from a mixed
infection were calculated as described previously (2).
VOL. 62, 1988
4020 LI AND BALTIMORE
synthesis. Because elongation of RNA chains appears to
require only protein 3D (the polymerase [36]), a likely role
for 2C is in initiation of RNA synthesis, a process whose
mechanism is still shrouded.
Guanidine inhibition has been ascribed both to inhibition
of release of RNA chains from the replication complex (11),
a process about which little is known, and to inhibition of
initiation of RNA chains (7, 8, 34). Because temperature
shift experiments with mutant 2C-31 showed no excess of
double-stranded RNA, while guanidine inhibition does pro-
duce such an excess, the two mechanisms of inhibition could
be different. Thus, there may be multiple functions per-
formed by 2C.
It has been observed that protein 2C (or its precursors) is
first free in the cytoplasm after being synthesized in the
virus-infected cells and then becomes associated with mem-
branous structures in which viral RNA synthesis proceeds
(4). One function of 2C, therefore, may be to attach the viral
RNA polymerase (6), the viral RNA, or the viral replication
complex as a whole onto membranes (4).
The nature of the lesions in protein 2C caused by the 2C-31
and 2C-32 mutations is unclear. They do not affect the
cleavage of 2C from its precursors but could affect its folding
pathway or its functional sites. The loss of RNA synthesis
after a shift to nonpermissive temperature late in the infec-
tion cycle points to a continual need for 2C, but that could be
either a consequence of a denaturing effect on 2C or a need
for newly made 2C. Viral RNA synthesis proceeds normally
even if viral protein synthesis is seriously curtailed (3), so
relatively small amounts of protein 2C should suffice for
normal RNA synthesis. However, larger amounts may be
needed when protein synthesis is normal to maintain the
stoichiometry of possible protein-protein complexes.
With mutant 2C-31, the requirement for protein 2C could
be provided very efficiently in trans. This contrasts to
certain guanidine-dependent (resistant) alleles that are virtu-
ally noncomplementable (12). It could be that 2C is needed in
cis for one function but can be provided in trans for others.
We previously noted that many of the loci involved in RNA
synthesis are cis active (2), possibly because of an involve-
ment in initial negative-strand synthesis.
Of 10 cDNA constructs that carried a linker insertion in
the 2C-encoding sequence, only the two reported here gave
rise to viable viruses (Fig. 1). All the other introduced
mutations apparently were lethal to viral replication. It is
possible that this region of the viral genome, given the fact
that it is highly conserved among various picornaviruses, is
extremely sensitive to changes. Alternatively, perturbation
of polyprotein secondary structure by the mutations could
prevent proper cleavage.
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